Status:
COMPLETED
Effect of Vit D on New-onset AF in Hypertension
Lead Sponsor:
Ankara University
Conditions:
Atrial Fibrillation
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Atrial fibrillation (AF), an important cause of cardiac mortality and morbidity is the most common type of cardiac arrhythmia in clinical practice. Hypertensive individuals are at particular risk of d...
Eligibility Criteria
Inclusion
- Hypertensive patients with new-onset AF
Exclusion
- Established coronary artery disease
- Heart failure
- Chronic obstructive pulmonary disease
- Diabetes mellitus
- Significant heart valve disease
- Hyperthyroidism
- Renal failure
- Any malignancy
- Acute infection
- Recent thoracic or abdominal surgery
- Under therapy of Vit D3
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT02298738
Start Date
January 1 2012
End Date
November 1 2014
Last Update
November 24 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.